[{"Row" : 1, "Column" : 1, "Item" : "ORZID GMENU ER/UC ABX GENERAL INFORMATION ED", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (ED)", "Header" : 0}, 
{"Row" : 9, "Column" : 1, "Item" : "ORZ GTX ABX URL MINNEAPOLIS COVID SHAREPOINT SITE", "Text" : "[Link] COVID-19 SharePoint Site", "Header" : 0}, 
{"Row" : 7, "Column" : 1, "Item" : null, "Text" : "site for inclusion/exclusion criteria, supportive care and additional ",  "Header" : 0}, 
{"Row" : 8, "Column" : 1, "Item" : null, "Text" : "information, "Column" : ",  "Header" : 0}, 
{"Row" : 15, "Column" : 1, "Item" : null, "Text" : "_______________________________________________________________________________ ",  "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX ABX ON-CALL SCHEDULE", "Text" : "[Link] Minneapolis On-Call Schedule-Infectious Disease", "Header" : 0}, 
{"Row" : 6, "Column" : 1, "Item" : null, "Text" : "Refer to the Pharmacologic Treatment Guidance on the COVID-19 SharePoint",  "Header" : 0}, 
{"Row" : 11, "Column" : 1, "Item" : null, "Text" : "***COVID-19 therapy is a rapidly evolving field, including the widespread ",  "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Item" : null, "Text" : "dissemination of therapies with little or no evidence for benefit, "Column" :  Therapies",  "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : null, "Text" : "and dosages not specifically listed here or on the NIH clinical guidelines",  "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : null, "Text" : "should be discussed with the infectious diseases service, "Column" : ***",  "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX SOTROVIMAB EUA", "Text" : "Sotrovimab (EUA) [may be ordered by ED/ID]", "Header" : 0}, 
{"Row" : 23, "Column" : 1, "Item" : null, "Text" : "Outpatients who are Priority 1 for Monoclonal Antibody Treatment: ",  "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Item" : null, "Text" : "*Unvaccinated OR partially vaccinated OR vaccinated veterans not expected to",  "Header" : 0}, 
{"Row" : 25, "Column" : 1, "Item" : null, "Text" : "mount an immune response <AND>",  "Header" : 0}, 
{"Row" : 26, "Column" : 1, "Item" : null, "Text" : "*Tested positive for COVID-19 <AND> ",  "Header" : 0}, 
{"Row" : 27, "Column" : 1, "Item" : null, "Text" : "*Within 5 days of (mild to moderate) symptom onset <AND>",  "Header" : 0}, 
{"Row" : 30, "Column" : 1, "Item" : null, "Text" : "If patient meets all of the above criteria: ",  "Header" : 0}, 
{"Row" : 34, "Column" : 1, "Item" : null, "Text" : "MONOCLONAL ANTIBODY SCREENING SCORE-BIPOC+PREGNANT (MASSBP) ",  "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Item" : null, "Text" : "*MASSBP score > 4 (see point system at bottom of menu)",  "Header" : 0}, 
{"Row" : 32, "Column" : 1, "Item" : null, "Text" : "____________________________________________________________________________",  "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : null, "Text" : "POSSIBLY BENEFICIAL THERAPIES - AVAILABLE BY EMERGENCY USE AUTHORIZATION (EUA)",  "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Item" : null, "Text" : "Total:",  "Header" : 0}, 
{"Row" : 46, "Column" : 1, "Item" : null, "Text" : ">>MASSBP equals total of points for each of patient's conditions above",  "Header" : 0}, 
{"Row" : 35, "Column" : 1, "Item" : null, "Text" : "o Age greater than 65:2 points",  "Header" : 0}, 
{"Row" : 36, "Column" : 1, "Item" : null, "Text" : "o BMI greater than 35:2 points",  "Header" : 0}, 
{"Row" : 37, "Column" : 1, "Item" : null, "Text" : "o Diabetes mellitus: 2 points ",  "Header" : 0}, 
{"Row" : 38, "Column" : 1, "Item" : null, "Text" : "o Cardiovascular disease over the age of 55: 1 point",  "Header" : 0}, 
{"Row" : 39, "Column" : 1, "Item" : null, "Text" : "o Immunocompromised status:4 points ",  "Header" : 0}, 
{"Row" : 40, "Column" : 1, "Item" : null, "Text" : "o BIPOC status:2 points ",  "Header" : 0}, 
{"Row" : 41, "Column" : 1, "Item" : null, "Text" : "o Pregnancy:4 points",  "Header" : 0}, 
{"Row" : 42, "Column" : 1, "Item" : null, "Text" : "o Chronic kidney disease: 3 points",  "Header" : 0}, 
{"Row" : 43, "Column" : 1, "Item" : null, "Text" : "____________________________________________________",  "Header" : 0}, 
{"Row" : 21, "Column" : 1, "Item" : "ORZ GTX ABX COVID-19 MONOCLONAL ANTIBODY SOP", "Text" : "Monoclonal Antibody Allocation SOP", "Header" : 0}, 
{"Row" : 19, "Column" : 1, "Item" : null, "Text" : "For more information on prioritization of COVID-19 monoclonal antibodies",  "Header" : 0}, 
{"Row" : 20, "Column" : 1, "Item" : null, "Text" : "for treatment due to supply constraints:",  "Header" : 0}, 
{"Row" : 4, "Column" : 1, "Item" : null, "Text" : "MPLS ED COVID-19 MONOCLONAL ANTIBODY PHARMACOLOGIC RECOMMENDATIONS", "Header" : 1}]
